Comparative cutoff points for adenosine monophosphate and methacholine challenge testing (Q45134915)

9 December 2017

Comparative cutoff points for adenosine monophosphate and methacholine challenge testing (English)

1 reference

9 December 2017

Tom C Fardon

1

1 reference

9 December 2017

Emma J Fardon

series ordinal

2

1 reference

9 December 2017

Melissa R Hodge

series ordinal

3

1 reference

9 December 2017

Brian J Lipworth

series ordinal

4

1 reference

9 December 2017

1 October 2004

1 reference

Annals of Allergy, Asthma & Immunology

9 December 2017

1 reference

9 December 2017

93

1 reference

9 December 2017

4

1 reference

9 December 2017

365-372

1 reference

Standardization of bronchial inhalation challenge procedures

9 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

A survey of the current use and methods of analysis of bronchoprovocational challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Interpretation of Eucapnic Voluntary Hyperventilation in the Diagnosis of Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Effects of mediator antagonism on mannitol and adenosine monophosphate challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Estimation and repeatability of the response to inhaled histamine in a community survey

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Evaluation of methacholine dose-response curves by linear and exponential mathematical models: goodness-of-fit and validity of extrapolation.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Methacholine PC20 extrapolation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Histamine PC(20) extrapolation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

Adenosine monophosphate bronchial provocation and the actions of asthma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961396-8

7 January 2021

10.1016/S1081-1206(10)61396-8

Identifiers

DOI

1 reference

9 December 2017

1 reference